Anavex Life Sciences Corp (AVXL)

[cadno]

Say the stock is $35+ around approval. An offer is made for $50/share. Missling has a little over 1,000,000 shares. That's $50 million. How many shares does Skarpelos have? I assume more, so north of that. I'm sure Missling has plenty of options as well.

I don't regard that as "on the cheap."

I do agree that there are some clear differences with KITE, but institutional ownership could change very quickly. If there is sustained good news, don't you think institutions would start taking much bigger positions in AVXL?

I'm not trying to throw in red herrings. Perhaps the Board is heavily committed in taking AVXL, on its own, to being a big cap pharma. I certainly hope so. I am invested in AVXL.